Example: biology
AUSTRALIAN PRODUCT INFORMATION – COMIRNATY …
Version: pfpcovii50121 Supersedes: N/A Page 3 of 15 Attachment 1: AusPAR – COMIRNATY - BNT162b2 (mRNA) - Pfizer Australia Pty Ltd - PM-2020-05461-1-2
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Guideline for the labelling of medicines
www.tga.gov.auGuideline for the labelling medicines of istorical consultation document Draft - Version 1.0, August 2014
Australian public assessment report for Linagliptin
www.tga.gov.au• An Australian Public Assessment Record (AusPAR) provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve a prescription medicine submission.
Australian Public Assessment Report for Silodosin
www.tga.gov.auAustralian Public Assessment Report for Silodosin Proprietary Product Name: Urorec ... • To report a problem with a medicine or medical device, please see the information on ... //www.tga.gov.au>. About AusPARs • An Australian Public Assessment Re port (AusPAR) provides information about the evaluation of a prescription medicine and the ...
Guidance 18: Impurities in drug substances and …
www.tga.gov.auTherapeutic Goods Administration Guidance 18: Impurities in drug substances and drug products V1.0 August 2013 Page 3 of 13 Version history Version Description of change Author Effective date
Explanatory notes for pharmaceutical manufacturers on the ...
www.tga.gov.auPE 008-4 3 of 8 1 January 2011 4. SCOPE These Explanatory Notes apply to the preparation and content of the Site Master File. Manufacturers should refer to regional / …
The use of GMDN codes for IVD medical devices in Australia
www.tga.gov.auGlobal Medical Device Nomenclature (GMDN) The GMDN is an international nomenclature system used by regional or national regulatory bodies to consistently describe medical devices: 1 • consistent assessment of devices before they are approved for supply . GMDN codes are used to
COMIRNATY™ COVID-19 VACCINE
www.tga.gov.auDo not receive this vaccine if you are allergic to any of these ingredients. What COMIRNATY looks like COMIRNATY is a white to off-white suspension provided in a multidose clear glass vial. After dilution, each vial contains 6 doses of vaccine. AUST R 346290. Who distributes COMIRNATY Pfizer Australia Pty Ltd Sydney NSW www.pfizer.com.au
COVID-19 rapid antigen self-tests
www.tga.gov.auCOVID-19 rapid antigen self-tests. This guidance refe rs to COVID -19 (caused by SARS-CoV-2) only and does not include self-tests to detect other types of coronavirus , or COVID_19 rapid antibody tests . COVID-19 rapid antigen self-tests are tests that allow individuals to collect a specimen, conduct a test and interpret the results by themselves.
AUSTRALIAN PRODUCT INFORMATION (ChAdOx1-S) …
www.tga.gov.auAUSTRALIAN PRODUCT INFORMATION COVID-19 Vaccine AstraZeneca (ChAdOx1-S) solution for injection . 1 NAME OF THE MEDICINE . ChAdOx1-S (provisional ABN) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION . Each multi-dose vial contains 5x10. 11. viral particles (vp) of (ChAdOx1-S . a, b) in 5 mL. One dose (0.5 mL) contains 5x10. 10. vp of …
Australian public assessment report for BNT162b2 (mRNA)
www.tga.gov.auThe RNA is encapsulated in lipid nanoparticles (LNPs), which enables entry into host cells, expression of the S protein, and elicitation of both antibody and cellular immune responses. The vaccine is supplied as a white to off white sterile frozen liquid, packaged in a multi dose clear glass 2 mL vial with a rubber stopper,
Related documents
London, 20 November 2008 - European Commission
ec.europa.eumicrogram, not 0.25 mg). However, where a range of medicinal products of the same pharmaceutical form includes strengths of more than one unit (e.g. 250 microgram, 1 mg and 6 mg), it may be more appropriate in certain cases to state the strengths in the same unit for the purpose of comparability (e.g. 0.25 mg, 1 mg and 6 mg).
Betamethasone 500 microgram soluble tablets used as …
mft.nhs.ukBetamethasone 500 microgram soluble tablets used as mouthwash What are the aims of this leaflet? This leaflet has been written to help you understand more about Betamethasone soluble tablets and how they are used as a mouthwash.
PACKAGE LEAFLET: INFORMATION FOR THE USER Spiolto …
www.medicines.org.uk2.5 microgram/2.5 microgram, inhalation solution tiotropium/olodaterol Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist.
A Rapid and Sensitive Method for the Quantitation of ...
hoffman.cm.utexas.eduMicrogram Quantities of Protein Utilizing the Principle of Protein-Dye Binding MARION M. BRADFORD Reproduction Research Laboratories, Department of Biochemistry, University of Georgia, Athens, Georgia 30602 Received September 11, 1975; accepted January 29, 1976
Quantity Limit Program - BCBSM
www.bcbsm.comSC = subcutaneous, mg = milligram, gm = gram, mcg = microgram, ml = milliliter, IU = international unit Not covered: You may be responsible for the full cost of the medication. Not applicable: Quantity limits may not apply. Sample Abilify MyCite = brand name (aripiprazole) = generic name Quantity limits for: Medication BCBSM Clinical ,CustomClosed
Formulas for Calculating Medication Dosage
www.indianhills.eduCalculating by microgram per kilogram per minute (mcg/kg/min) Ordered mcg/kg/min x Patient weight in kg x 60 minutes/h ----- = mL/h Medication concentration (mcg/1 mL) 800 mg of dopamine is added to 250 ml of .9%Ns. The order is to begin the infusion at 3 mcg/kg/minute.
UNITED KINGDOM USER PACKAGE LEAFLET OF CERAZETTE
www.medicines.org.uk75 microgram film-coated tablets . desogestrel . Read all of this leaflet carefully before you start using this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have any further questions, please ask your doctor, pharmacist or Family Planning Nurse.
Pfizer-BioNTech COVID-19 Vaccines
www.cdc.gov10/7/2021 Pfizer-BioNTech COVID-19 Vaccines PRELIMINARY – SUBJECT TO CHANGE PENDING REGULATORY GUIDANCE AND AUTHORIZATION/APPROVAL *Diluent: 0.9% sterile Sodium Chloride Injection, USP (non-bacteriostatic; DO NOT USE OTHER DILUENTS)